HDA ACCREDITED PHARMACEUTICAL GOOD DISTRIBUTION PRACTICE PCSC

Serial Number 98539102
681

Registration Progress

Application Filed
May 8, 2024
Under Examination
Approved for Publication
Published for Opposition
Jul 22, 2025
Registered

Trademark Image

HDA ACCREDITED PHARMACEUTICAL GOOD DISTRIBUTION PRACTICE PCSC

Basic Information

Serial Number
98539102
Filing Date
May 8, 2024
Published for Opposition
July 22, 2025
Drawing Code
3

Status Summary

Current Status
Active
Status Code
681
Status Date
Jul 3, 2025
Application
Pending
Classes
B

Rights Holder

Healthcare Distribution Alliance

99
Address
1275 Pennsylvania Ave., NW
Suite 600
Washington, DC 20004

Ownership History

Healthcare Distribution Alliance

Original Applicant
99
Washington, DC

Legal Representation

Attorney
Luna Samman

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

24 events
Date Code Type Description
Jun 19, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 3, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 3, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN
Jun 3, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED
Jun 3, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED
Mar 14, 2025 CNFR R FINAL REFUSAL WRITTEN
Mar 14, 2025 GNFR O FINAL REFUSAL E-MAILED
Mar 14, 2025 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 4, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 4, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 4, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 20, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 20, 2025 ALIE A ASSIGNED TO LIE
Feb 13, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 13, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 13, 2025 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Feb 13, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 5, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 5, 2024 CNRT R NON-FINAL ACTION WRITTEN
Dec 5, 2024 GNRT F NON-FINAL ACTION E-MAILED
Nov 21, 2024 DOCK D ASSIGNED TO EXAMINER
Nov 7, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 7, 2024 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
May 8, 2024 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class B

Additional Information

Design Mark
The mark consists of a solid blue circle enclosing the term "HDA" in white next to three arcs in yellow and orange above the term "ACCREDITED" in blue and encased in an orange band, all enclosed in a white circle with a blue border framing the terms "PHARMACEUTICAL GOOD DISTRIBUTION PRACTICE" in blue with small blue circles on either side and "PCSC" in blue next to an orange and yellow shield.
Color Claim
The color(s) blue, yellow, orange and white is/are claimed as a feature of the mark.
Other
The certification mark, as used or intended to be used by persons authorized by the certifier, certifies or is intended to certify that the services provided have met the certifier's standards as to logistics, transportation, distribution, and storage services for goods in the pharmaceutical, medical and life sciences industries.

Classification

International Classes
B

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"ACCREDITED PHARMACEUTICAL GOOD DISTRIBUTION PRACTICE"

USPTO Documents

Click to view cached USPTO documents for this trademark

Only administrators can request new documents from USPTO